Host Graft Interactions
Host Graft Interactions - Related Videos
09:00
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
0 Views •
Cited by 14 •
2012
High throughput validation of multiple candidate biomarkers can be performed by sequential ELISA in order to minimize freeze/thaw cycles and use of precious plasma samples. Here, we demonstrate how to sequentially perform ELISAs for six different validated plasma biomarkers1-3 of graft-versus-host disease (GVHD)4 on the same plasma sample.
12:22
Biomimetic Materials to Characterize Bacteria-host Interactions
0 Views •
Cited by 8 •
2015
Bacterial attachment to host cells is a key step during host colonization and infection. This protocol describes the generation of polymer-coupled recombinant adhesins as biomimetic materials which allow analysis of the contribution of individual adhesins to these processes, independent of other bacterial factors.
04:06
Assessing Bacteria-Host Cell Interactions Using Biomimetic Beads
0 Views •
2025
Source: Stones, D. H., et al. Biomimetic Materials to Characterize Bacteria-host Interactions. J. Vis. Exp. (2015)This video demonstrates the use of bacteriomimetic beads to quantify bacterial adhesion to host epithelial cells under competitive conditions. It outlines the steps involved in treating the cells, lysing them, and plating serial dilutions to measure colony-forming units.
13:56
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
0 Views •
Cited by 4 •
2013
This article focuses on the identification of high-confident interaction datasets between host and pathogen proteins using a combination of two orthogonal methods: yeast two-hybrid followed by a high-throughput interaction assay in mammalian cells called HT-GPCA.
02:14
Preparation of Streptococcus mitis Culture for Host-Pathogen Interaction Studies
0 Views •
2025
Source: Naji, A., et al. Studying Oxidative Stress Caused by the Mitis Group Streptococci in Caenorhabditis elegans. J. Vis. Exp. (2019).This video demonstrates the method for culturing Streptococcus mitis under microaerophilic conditions using Todd-Hewitt Yeast Extract, or THY agar medium, to prepare bacterial cultures for host-pathogen interaction studies.
FAQs
Donor major histocompatibility complex molecules provide prominent recognition signals for the recipient’s immune system. When host immune cells identify these molecules, they can activate T cells and initiate responses directed at the graft. The strength and character of this recognition help determine whether the implanted tissue remains accepted, undergoes injury, or progresses toward rejection.
Several pathways may contribute to graft injury, including activated T cells, antibodies, and inflammatory responses. These mechanisms can act independently or together after donor antigens are recognized. In some transplant settings, immune cells carried within the graft can instead attack recipient tissues, creating a distinct direction of immune injury that must also be considered.
Outcomes depend partly on how the recipient’s immune system responds to donor major histocompatibility complex molecules and other antigens. Donor matching can influence this recognition, while immunosuppressive therapy can alter the resulting immune activity. These variables help explain why some grafts are accepted, whereas others experience injury or rejection despite transplantation.
Donor matching is used to address the immune differences that can trigger recognition of a graft. By considering compatibility between donor and recipient, clinicians seek to reduce problematic immune activation and improve the likelihood of graft acceptance. Matching therefore works alongside immunosuppressive therapy and post-transplant monitoring rather than replacing those measures.
Post-transplant management includes monitoring for signs of rejection and evaluating whether the graft remains accepted. This surveillance is important because host immune activity may injure the implanted tissue or organ after recognition has occurred. Findings from monitoring can inform the ongoing use of immunosuppressive therapy and support earlier responses to an unfavorable outcome.
Understanding immune recognition and graft injury helps researchers design safer approaches to tissue engineering and regenerative medicine. These fields must account for how implanted cells, tissues, or organs interact with the recipient’s immune system. Strategies that promote immune tolerance are especially relevant because they aim to support durable integration while limiting damaging host responses.